Literature DB >> 15355354

Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18.

Sébastien Soubeyrand1, Caroline Schild-Poulter, Robert J G Haché.   

Abstract

Phosphorylation at multiple sites within the N-terminus of p53 promotes its dissociation from hdm2/mdm2 and stimulates its transcriptional regulatory potential. The large phosphoinositide 3-kinase-like kinases ataxia telangiectasia mutated gene product and the ataxia telangectasia and RAD-3-related kinase promote phosphorylation of human p53 at Ser15 and Ser20, and are required for the activation of p53 following DNA damage. DNA-dependent protein kinase (DNA-PK) is another large phosphoinositide 3-kinase-like kinase with the potential to phosphorylate p53 at Ser15, and has been proposed to enhance phosphorylation of these sites in vivo. Moreover, recent studies support a role for DNA-PK in the regulation of p53-mediated apoptosis. We have shown previously that colocalization of p53 and DNA-PK to structured single-stranded DNA dramatically enhances the potential for p53 phosphorylation by DNA-PK. We report here the identification of p53 phosphorylation at two novel sites for DNA-PK, Thr18 and Ser9. Colocalization of p53 and DNA-PK on structured DNA was required for efficient phosphorylation of p53 at multiple sites, while specific recognition of Ser9 and Thr18 appeared to be dependent upon additional determinants of p53 beyond the N-terminal 65 amino acids. Our results suggest a role for DNA-PK in the modulation of p53 activity resultant from the convergence of p53 and DNA-PK on structured DNA. Copyright 2004 FEBS

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355354     DOI: 10.1111/j.1432-1033.2004.04319.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient.

Authors:  Samuel Regan; Xuebin Yang; Niklas K Finnberg; Wafik S El-Deiry; Jeffrey J Pu
Journal:  Cancer Biol Ther       Date:  2019-08-18       Impact factor: 4.742

2.  The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation.

Authors:  Jia Liu; Janice R Naegele; Stanley L Lin
Journal:  Brain Res       Date:  2009-08-04       Impact factor: 3.252

3.  DNA Repair Defects and DNA-PK in Neurodegeneration.

Authors:  Jyotshna Kanungo
Journal:  Cell Dev Biol       Date:  2012-05-25

4.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

5.  Flexible Tethering of ASPP Proteins Facilitates PP-1c Catalysis.

Authors:  Yeyun Zhou; Robyn Millott; Hyeong Jin Kim; Shiyun Peng; Ross A Edwards; Tamara Skene-Arnold; Michal Hammel; Susan P Lees-Miller; John A Tainer; Charles F B Holmes; J N Mark Glover
Journal:  Structure       Date:  2019-08-08       Impact factor: 5.006

6.  High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.

Authors:  Natalia Krynetskaia; Hongbo Xie; Slobodan Vucetic; Zoran Obradovic; Evgeny Krynetskiy
Journal:  Mol Pharmacol       Date:  2007-10-19       Impact factor: 4.436

7.  HMGB1 bound to cisplatin-DNA adducts undergoes extensive acetylation and phosphorylation in vivo.

Authors:  Yafeng He; Yin Ding; Dan Wang; Wanjun Zhang; Weizhong Chen; Xichun Liu; Weijie Qin; Xiaohong Qian; Hao Chen; Zijian Guo
Journal:  Chem Sci       Date:  2014-12-15       Impact factor: 9.825

8.  EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma.

Authors:  Jie Ding; Xiaolong Li; Sabbir Khan; Chen Zhang; Feng Gao; Shayak Sen; Amanda R Wasylishen; Yang Zhao; Guillermina Lozano; Dimpy Koul; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

Review 9.  DNA-dependent protein kinase and DNA repair: relevance to Alzheimer's disease.

Authors:  Jyotshna Kanungo
Journal:  Alzheimers Res Ther       Date:  2013-04-08       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.